Future heart problems could be predicted by smart watches.

Published Date: 05 Apr 2023

According to a new study led by UCL researchers, wearable technology like smart watches could be used to identify people who are more likely to experience heart failure and irregular heartbeats later in life.

Read Full News

Latest News

Common Kitchen Herbs May Help Prevent Obesity

Common culinary herbs such as cress, coriander, sage, and mint may help prevent and manage obesity by reducing inflammation, improving metabolic health, and supporting gut microbiota.

Insurers Fail to Get Specific on Prior Authorization Reforms

An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy.

MHRA Approves Olezarsen for Rare Lipid Disorder

The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.

Long COVID May Increase Your Heart Disease Risk

Individuals with long COVID face a substantially higher risk of developing cardiovascular disease — particularly cardiac arrhythmias and coronary artery disease — than those without long COVID.

Tirzepatide Bests Semaglutide in 12-Month Real-World Study

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

BP Lower Than Target in Many With Coronary Heart Disease

Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

Todays Updates

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Primary Care on the Front Lines of Mental Health Care

With a mental health care provider shortage and many patients’ seeking mental health support, primary care doctors have stepped up to the front lines.

Strategies for Latent TB Infection Screening and Care

While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

Todays Updates

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Primary Care on the Front Lines of Mental Health Care

With a mental health care provider shortage and many patients’ seeking mental health support, primary care doctors have stepped up to the front lines.

Strategies for Latent TB Infection Screening and Care

While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

Latest News

Common culinary herbs such as cress, coriander, sage, and mint may help prevent and manage obesity by reducing inflammation, improving metabolic health, and supporting gut microbiota.

An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy.

The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.

Individuals with long COVID face a substantially higher risk of developing cardiovascular disease — particularly cardiac arrhythmias and coronary artery disease — than those without long COVID.

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

News All Time

Stable Patients May Safely End Beta-Blockers Post-MI

Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking them, a study conducted in South Korea finds.

PVR Reduced in Adults With HFpEF, Pulmonary Hypertension

In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients with combined postcapillary and precapillary pulmonary hypertension and HFpEF.

Veterans Often Miss Out on Quadruple Therapy for HFrEF

Most US veterans who have new heart failure with reduced ejection fraction do not receive all four classes of guideline-directed medical therapy, and many die before starting full therapy, a study finds.

Empagliflozin May Boost Exercise Tolerance in T2D

In patients with type 2 diabetes, 6 months of empagliflozin therapy vs sitagliptin therapy is tied to a modest increase in the fat oxidation rate during exercise of low-to-moderate intensity.

Should Your Patient Be on Statins? Maybe the Eyes Can Tell

A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy.

Europe’s DNR Divide: Why CPR Discussions Are So Difficult

How do you speak with a deteriorating, in-hospital patient about resuscitation decisions? Physician confidence and legal frameworks vary, with direct impacts on patients.

Fluid Monitoring Device Can Improve HFpEF Outcomes

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients with heart failure with preserved ejection fraction.

Liraglutide Lessens Sleep Apnea in COPD With Obesity

Liraglutide reduced obstructive sleep apnea severity and improved quality of life in patients with overweight or obesity and COPD in a randomized trial.

Inside the Quest to Predict Disease Before Symptoms Strike

From smartwatches to DNA fragments, scientists are building a ‘dashboard’ for human health, but a high-profile trial shows how difficult it is to prove the tech can save lives.

Australia Bans Use of Genetic Testing Data by Life Insurers

Australia has banned life insurance companies from using genetic testing information to deny or restrict policies.

Can Vitamin D Promote a Healthier Gut in IBD?

Vitamin D supplementation is linked to less disease activity and inflammation in inflammatory bowel disease and may restore healthy interactions between the immune system and the gut.

Two Oral GLP-1s Increase Options for Patient Care

Eli Lilly and Novo Nordisk are in heated competition over orforglipron versus oral semaglutide, respectively, while injectables remain the more potent obesity treatment options.

Impella Comes Up Short in High-Risk PCI: CHIP-BCIS3

High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump during complex PCI procedures than those provided with a microaxial flow pump.

Shingles Vaccine Lowers Cardiovascular Risk

Patients with atherosclerotic cardiovascular disease who had received herpes zoster vaccination saw reductions in major adverse cardiac events.

Younger Age Offers No Protection From HFrEF Deaths

Patients with heart failure with reduced ejection fraction, especially those aged 40-49 years, have higher 5-year mortality than peers from the general population.

Active Breath Control Cuts Radiation Dose to Heart

Active breath control significantly reduced radiation dose to the heart and a major artery during treatment for left-sided breast cancer, new data show.

Recommended News For You

We Don't Always Know What's 'Best' for Our Patients

Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

How a California Oncologist Making $850k Spends Money

The Kansas Cancer Center awarded two Indian American doctors professorships.

Should the UK introduce targeted prostate cancer screening? The case for and against

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Recommended Articles For You

Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment 

Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern  

Neutrophil Profiling and AI Rewrites Cancer Diagnosis 

Decoding Efficacy, Safety, and Future Frontiers in CAR-T Cell Therapy for Hematologic Malignancies Towards CAR-T Therapy 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

2.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

3.

Using AI, one can find cancer risk factors.

4.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

5.

Optimizing Sequencing of BCMA-Directed Therapies in Myeloma

1.

How to Prevent Tumor Lysis Syndrome in Cancer Patients

2.

Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies

3.

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans

4.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

5.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XII

2.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

3.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

4.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot